###begin article-title 0
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
###end article-title 0
###begin p 1
###xml 95 111 95 111 <email xmlns:xlink="http://www.w3.org/1999/xlink">kraemerk@nih.gov</email>
To whom correspondence should be addressed. Tel: +1 301 496 9033; Fax: +1 301 496 8419; Email: kraemerk@nih.gov
###end p 1
###begin p 2
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 462 465 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 646 649 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 799 802 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1006 1009 970 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1099 1102 1063 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
XPC DNA repair gene mutations result in the cancer-prone disorder xeroderma pigmentosum. The XPC gene spans 33 kb and has 16 exons (82-882 bp) and 15 introns (0.08-5.4 kb). A 1.6 kb intron was found within exon 5. Sensitive real- time quantitative reverse transcription-polymerase chain reaction methods were developed to measure full-length XPC mRNA (the predominant form) and isoforms that skipped exons 4, 7 or 12. Exon 7 was skipped in approximately0.07% of XPC mRNAs, consistent with the high information content of the exon 7 splice acceptor and donor sites (12.3 and 10.4 bits). In contrast, exon 4 was skipped in approximately0.7% of the XPC mRNAs, consistent with the low information content of the exon 4 splice acceptor (-0.1 bits). A new common C/A single nucleotide polymorphism in the XPC intron 11 splice acceptor site (58% C in 97 normals) decreased its information content from 7.5 to 5.1 bits. Fibroblasts homozygous for A/A had significantly higher levels (approximately2.6-fold) of the XPC mRNA isoform that skipped exon 12 than those homozygous for C/C. This abnormally spliced XPC mRNA isoform has diminished DNA repair function and may contribute to cancer susceptibility.
###end p 2
###begin p 3
DDBJ/EMBL/GenBank accession nos AF261892-AF261901
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c1">1</xref>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c2">2</xref>
###xml 267 268 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c3">3</xref>
###xml 269 270 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c4">4</xref>
###xml 482 483 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c1">1</xref>
###xml 490 493 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 575 576 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c5">5</xref>
###xml 577 578 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c7">7</xref>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
Xeroderma pigmentosum (XP) is an autosomal recessive disease with defective nucleotide excision repair (NER) (1,2). XP patients have a high incidence of skin cancers (approximately1000 times that of the general population) which occur at an average age of <10 years (3,4). The defects in XP patients fall into seven NER complementation groups: XP-A to XP-G and a separate group XP variant (XP-V) with a defect in DNA polymerase eta. XP-C is one of the more common forms in the USA (1). The XPC gene encodes a 940 amino acid protein uniquely involved in global genome repair (5-7).
###end p 5
###begin p 6
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 817 820 817 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
We examined the structure of the human XPC gene in order to determine its arrangement and splicing signals. Extremely sensitive real-time quantitative reverse transcription-polymerase chain reaction (QRT-PCR) assays were developed to measure full-length XPC message as well as alternatively spliced isoforms that skip exon 4, 7 or 12. We found that a splice acceptor with high information content had a low level of alternatively spliced isoform, while a splice acceptor with low information content was associated with a higher level of exon skipping. A common single nucleotide polymorphism (SNP) in a splice acceptor reduced its information content and was associated with increased skipping of exon 12. Utilizing a post-UV host cell reactivation assay we have demonstrated that cells with increased levels of the XPC isoform that skips exon 12 have reduced DNA repair function.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Cell lines, culture conditions and DNA/RNA isolation
###end title 8
###begin p 9
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c5">5</xref>
###xml 1023 1024 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c8">8</xref>
###xml 170 175 <span type="species:ncbi:9606">Human</span>
###xml 363 370 <span type="species:ncbi:9606">patient</span>
###xml 401 406 <span type="species:ncbi:9606">Human</span>
###xml 444 448 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 694 698 <span type="species:ncbi:9913">calf</span>
###xml 812 816 <span type="species:ncbi:9913">calf</span>
###xml 1310 1315 <span type="species:ncbi:9606">human</span>
Normal primary fibroblasts (AG04349, AG13145, AG13153, AG04659, AG05186, AG13354, AG13129, AG06239 and AG04438) and lymphoblastoid cells (AG10107) were obtained from the Human Aging Cell Repository (Camden, NJ) through the assistance of Dr J. Metter (National Institute on Aging, Baltimore, MD). XP heterozygote lymphoblast line KR04491 (XPH310BE, mother of XP-C patient XP25BE) was obtained from the Human Mutant Cell Repository (Camden, NJ). SV40-transformed XP-C (XP4PA-SV-EB) cells (5) were a gift from Dr R. Legerski (M.D. Anderson Hospital, Houston, TX). Fibroblast cell lines were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) containing 40 mM glutamine, and 15% fetal calf serum (Hyclone Laboratories Inc., Logan, UT). Lymphoblastoid cells were grown in RPMI 1640 medium with 10% fetal calf serum. Exposure to emetine (300 microg/ml) (Sigma-Aldrich Chemical Co., St Louis, MO) in serum-free DMEM for 2 h was used to reverse the premature termination codon-mediated mRNA decay in some experiments (8). Total cytoplasmic RNA was isolated from cells using the RNAqueous small scale phenol-free total RNA isolation kit (Ambion, Austin, TX) as per the vendor's protocol. DNA was isolated utilizing DNAzol reagent as per the vendor's protocol (Invitrogen). Measurement of mRNA in 24 normal human tissues utilized Rapid-Scan gene expression panels (catalogue no. HSCA-101; Origene Technologies, Rockville, MD), using the real-time QRT-PCR assays described below.
###end p 9
###begin title 10
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
PCR amplification and sequencing of XPC exons and introns including splice donor and acceptor sites
###end title 10
###begin p 11
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c5">5</xref>
###xml 901 904 889 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
In order to determine the DNA sequences at the splice donor and acceptor sites of all of the 16 XPC exons, each exon and their respective splice donor and acceptor sites were PCR amplified using a total of 17 intronic primers flanking these sequences, as shown in supplementary Table A. The primers listed in supplementary Table B were used to amplify the XPC introns. The primers were designed on the basis of the XPC cDNA and the sequences we submitted (GenBank accession nos AF261892-AF261901) or the GenBank reference sequence (accession no. AC090645). Some of the primers were previously reported (5). PCR amplification and DNA sequencing were performed using the conditions described in the Supplementary Material. A total of 16 primer pairs (in either an exon or an intron) were employed using the PCR conditions described in the Supplementary Material to amplify the entire approximately33 kb XPC gene.
###end p 11
###begin title 12
DNA sequence information analysis
###end title 12
###begin p 13
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c9">9</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c10">10</xref>
Sequences were scanned with the donor and acceptor individual information weight matrices and the identified sites were displayed as described previously (9,10). These analyses can be performed on a Web server ().
###end p 13
###begin title 14
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Real-time QRT-PCR for XPC mRNA
###end title 14
###begin p 15
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 631 634 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 706 707 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
###xml 852 853 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
XPC mRNA isoforms were quantitated using isoform-specific real-time QRT-PCR as described in the Supplementary Material. Real-time QRT-PCR assays were carried out on a Bio-Rad iCycler iQ system (Bio-Rad, Hercules, CA) using intercalation of SYBR Green as the fluorescence reporter. Reactions were carried out using the SYBR Green kit from PE Applied Biosystems following the manufacturer's protocol. Isoform-specific real-time QRT-PCR assays were designed to discriminate between RNAs including or excluding specific exons (see supplementary Table C and Fig. S1). Primer sequences were based on the GenBank sequence for full-length XPC mRNA (accession no. D21089) and the exon junction information in Table 1. All primer pairs showed at least a 20 cycle difference between cDNA clones for exon inclusion and exon exclusion, indicating an approximately106-fold specificity. In preliminary experiments we determined that use of a primer that spans the junction of adjacent exons (supplementary Fig. S1) can eliminate the possibility of amplification of intron-containing sequences, thereby greatly reducing interference due to cross contamination of cDNA with genomic DNA (data not shown).
###end p 15
###begin p 16
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c5">5</xref>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
XPC cDNA standards for real-time QRT-PCR were generated by end-point PCR with the primers shown in supplementary Table C and subcloned with the TOPO TA cloning kit (Invitrogen) as per the vendor's protocol. The concentration of each standard was determined using picogreen (Molecular Probes) and also by real-time quantitative polymerase chain reaction using a primer pair for the ampicillin resistance gene (supplementary Table C). This approach allows data from all assays to be expressed in terms of fg XPC clone pXPC-3 (5) (this clone contains the partial XPC cDNA sequence GenBank accession no. NM_004628, which does not contain the first 272 nt of XPC cDNA GenBank accession no. D21089), thus facilitating comparison between assays. For reference purposes, there are approximately150 single-stranded DNA molecules per fg clone pXPC-3.
###end p 16
###begin title 17
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Determination of XPC intron 11 (-5 C-->A) acceptor site SNP
###end title 17
###begin p 18
###xml 484 487 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fau</italic>
###xml 642 645 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 666 669 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fau</italic>
###xml 677 680 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fau</italic>
The intron 11 -5 C-->A SNP was detected by PCR amplification of this region using the Advantage cDNA PCR kit (Clontech, CA) with forward primer E1 and reverse primer H2 (supplementary Table B) as per the manufacturer's protocol. The PCR steps were conducted as follows: 94degreesC for 3 min, then 35 cycles of amplification [94degreesC for 20 s (denaturation) and 67degreesC for 3 min (annealing/extension)], ending with 67degreesC for 3 min. The polymorphic position was analyzed by FauI restriction endonuclease (SibEnzyme) digestion of the 203 bp PCR products amplified from donor DNA using primer pairs E1 and H2. The C at position -5 of XPC intron 11 creates a FauI site. FauI digestion converts the 203 bp PCR product into two fragments of 43 and 160 bp. The fragments were resolved on 2% agarose gels.
###end p 18
###begin title 19
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Host cell reactivation assay and functional analysis of XPC mRNA isoforms
###end title 19
###begin p 20
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c11">11</xref>
###xml 290 291 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
The pCMVLuc reporter gene plasmid (a generous gift from M. Hedayati and L. Grossman, Johns Hopkins University, Baltimore, MD) was used to measure post-UV host cell reactivation as described previously (11). Briefly, 4 microl (200 ng) of CsCl-purified pCMVLuc, either UV-irradiated (1000 J/m2) or unirradiated, was transfected into cells using Lipofectamine (Invitrogen). After 48 h, the luciferase activity was measured with a luminometer (Monolight 2010; Analytical Luminescence Laboratory, San Diego, CA) using luciferase assay reagent (Promega) as per the vendor's protocol. Relative luciferase activities are presented as a percentage of activities obtained with UV-irradiated versus unirradiated control plasmids.
###end p 20
###begin p 21
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
In order to assess the function of the XPC mRNA isoform that skips exon 12, an expression vector plasmid containing the XPC cDNA with deletion of exon 12 (pcDNA3/HA-XPC-deleted-exon12) was constructed. The heterozygous XP-C cell line KR04491 was used as a source of cDNA with deletion of exon 12. This material was used to replace the same region of wild-type XPC cDNA in the expression vector plasmid pcDNA3/HA-XPC (a gift from Dr Fumio Hanaoka, Osaka University, Osaka, Japan).
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Structure of the normal XPC gene
###end title 23
###begin p 24
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 297 298 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f1">1</xref>
###xml 344 347 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 395 397 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c12">12</xref>
###xml 559 562 547 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 628 629 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f1">1</xref>
###xml 640 641 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
###xml 716 717 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f1">1</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
Detailed knowledge of the genomic structure of the human XPC gene is crucial for identifying the genotype of individuals with inherited defects and increased cancer risk. Primer pairs and sequencing conditions were developed to amplify 16 regions of the XPC gene spanning approximately33 kb (Fig. 1 and supplementary Tables A and B). The human XPC gene was previously reported to have 15 exons (12). We found an additional 1.6 kb intron within exon 5 (between nucleotides 726 and 727) that splits this region into exons 5.1 and 5.2. The 16 exons of the human XPC gene range in size from 82 bp (exon 10) to 882 bp (exon 8) (Fig. 1 and Table 1). The 15 introns vary from 0.08 kb (intron 11) to 5.4 kb (intron 1) (Fig. 1). The nucleotide sequence in 10 regions was determined and submitted to GenBank (accession nos AF261892-AF261901). The GenBank reference sequence AC090645 from high-throughput sequencing completes the gaps in the intron sequences.
###end p 24
###begin title 25
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Analysis of the XPC exon-intron boundaries
###end title 25
###begin p 26
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c12">12</xref>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
###xml 262 267 <span type="species:ncbi:9606">human</span>
Intron primers were developed to permit amplification of each of the 16 exons separately (supplementary Table A). All of the exon-intron junctions in the XPC gene were sequenced and some of the previously reported exon-intron boundaries were corrected (12). The human XPC gene intronic splice donor and acceptor site sequences and their location in the coding XPC sequence are listed in Table 1.
###end p 26
###begin p 27
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c9">9</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c10">10</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c9">9</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c13">13</xref>
###xml 801 803 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c14">14</xref>
###xml 825 828 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1071 1072 1059 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
The information contents of the XPC splice donor and acceptor sites were evaluated using an information theory-based approach incorporating information weight matrices that reflect features of nearly 2000 published donor and acceptor sites (9,10). Information is an additive measure of sequence conservation and describes the degree to which a member contributes to the conservation of an entire sequence family in contrast to examining only the consensus sequence (9,13). Information content is defined as the number of choices needed to describe a sequence pattern, using a logarithmic scale in bits. The magnitude of the information content indicates how strongly conserved a base is in natural splice junction binding sites, with approximately2.4 bits being the apparent minimal functional value (14). All but one of the XPC splice sites demonstrate information contents that range from 4.1 bits (donor splice site in intron 12) to 17.4 bits (acceptor splice site in intron 5.1), consistent with functional activity but with considerable variation in strength (Table 1). The exception is the acceptor splice site of intron 3, which possesses a very low information content (-0.1 bits).
###end p 27
###begin title 28
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Measurement of XPC mRNA levels by real-time QRT-PCR
###end title 28
###begin p 29
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c15">15</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c16">16</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c17">17</xref>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 914 917 914 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1039 1040 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 1138 1141 1124 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Real-time QRT-PCR is an extremely sensitive and specific technique for measurement of specific mRNA levels in human cells (for a review see 15). For this study isoform-specific primers were designed using the same principles that have been developed for allele-specific PCR (16,17). We first created an assay for XPC cDNA that includes exon 12 by designing a sense primer that recognizes the exon 11-exon 12 junction (oCCB-331) and pairing it with an antisense primer that is contained in exon 12 (oCCB-337, supplementary Fig. S1 and Table C). This assay was applied to RT reactions from duplicate RNA samples from nine normal skin fibroblast cultures (Table 2). Close agreement was found between duplicate samples. In addition, similar results were obtained using a second primer pair that detects the exon 12-exon 13 junction (oCCB-333 and oCCB-335 in supplementary Fig. S1; data not shown). The normal level of XPC cDNA was 294 +/- 15.7 fg pXPC-3 with a range of 197-348 fg based on measurement of message that contained exon 12 (Table 2). Assuming 100% efficiency of the RT reaction, this corresponds to an average of approximately10 XPC mRNA molecules/cell. However, since we do not know the efficiency of the RT reaction, all real-time QRT-PCR results will be expressed in terms of fg pXPC-3.
###end p 29
###begin title 30
Relationship of splice acceptor information content to extent of exon 4 and 7 skipping
###end title 30
###begin p 31
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c9">9</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c14">14</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c18">18</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
The information theory-based approach along with the exon recognition model of vertebrate splicing predicts that splice acceptors with high information content would be less likely to be associated with exon skipping than splice acceptors with low information content (9,14,18). We found that the splice acceptor for exon 7 had an information content of 12.3 bits, while that for exon 4 had an information content of -0.1 bits (Table 1). This predicts that normal cells would contain a smaller amount of alternatively spliced XPC mRNA that skipped exon 7 than XPC mRNA that skipped exon 4. Isoform-specific primers were developed for QRT-PCR to measure mRNA that skipped exon 7 (using oCCB-382, a primer that includes the junction of exons 6 and 8) and that skipped exon 4 (using oCCB-364, a primer that includes the junction of exons 3 and 5.1). These primers are designed only to detect exon skipping. For example, primer oCCB364 spans the exon 3-exon 5.1 junction and has a 3' two base mismatch with exon 4, which allows us to discriminate between the two isoforms (supplementary Fig. S1 and Table C). These were paired with primers oCCB-384 and oCCB-368, respectively.
###end p 31
###begin p 32
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 171 172 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 254 255 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 347 350 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 404 405 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 485 486 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
RT reactions from normal fibroblasts contained extremely little detectable XPC cDNA that skipped exon 7 (nine normal fibroblast lines had a mean of 0.2 +/- 0.01 fg; Table 2). This represents <0.07% of the full-length isoform that contains exon 12 (Table 2). In contrast, the same RT reactions had a 10-fold greater amount of alternatively spliced XPC cDNA that skipped exon 4 (mean 2.0 +/- 0.2 fg; Table 2). This represents 0.7% of the full-length isoform that contains exon 12 (Table 2).
###end p 32
###begin title 33
A common SNP in the intron 11 splice acceptor
###end title 33
###begin p 34
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fau</italic>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f2">2</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c19">19</xref>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f2">2</xref>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb3">3</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb3">3</xref>
A C/A SNP in the 3' end of XPC intron 11 at the -5 position was found where the C creates a new FauI restriction site (Fig. 2). We examined buccal DNA from 97 normal subjects, randomly selected among NIH employees (19), to determine the frequencies of this polymorphism by restriction fragment length polymorphism (RFLP) analysis (Fig. 2 and Table 3). This was a common polymorphism, with the C being present in 58% of the alleles and the A present in 42%. The observed genotype distribution was not significantly different from that expected by the Hardy-Weinberg theory (Table 3).
###end p 34
###begin p 35
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 222 226 222 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2920</sub>
###xml 232 235 232 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">939</sub>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c19">19</xref>
###xml 295 298 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 310 311 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f1">1</xref>
###xml 316 317 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f3">3</xref>
###xml 398 401 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 435 436 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb3">3</xref>
###xml 551 554 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 582 583 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f3">3</xref>
###xml 696 697 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 761 762 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 825 826 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f3">3</xref>
The distribution of the XPC intron 11 splice acceptor polymorphism was compared with that of two other polymorphisms in the XPC gene: a poly(AT) insertion/deletion polymorphism in intron 9 (PAT) and a SNP in XPC exon 15 (A2920C, Lys939Gln) (19). These markers are approximately9 kb apart in the XPC gene (Figs 1 and 3). Among the 97 normal donors, 59 (61%) were homozygous for either C or A in the XPC intron 11 splice acceptor (Table 3). These same 59 donors were also homozygous for the PAT polymorphism and 56 of the donors were homozygous for the XPC exon 15 polymorphism (Fig. 3, upper and middle). These three markers are in linkage disequilibrium and are consistent with a haplotype of PAT-/intron 11 C/exon 15 A in approximately60% of the donors and PAT+/intron 11 A/exon 15 C in approximately40% of the donors (Fig. 3, lower).
###end p 35
###begin title 36
Effect of a splice acceptor polymorphism on exon 12 skipping
###end title 36
###begin p 37
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f2">2</xref>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 843 844 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c8">8</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c20">20</xref>
###xml 912 915 912 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1061 1062 1061 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1116 1119 1116 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1215 1216 1215 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f4">4</xref>
###xml 1279 1280 1279 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1322 1325 1322 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 1362 1363 1362 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f4">4</xref>
Information theory analysis indicated that an intron 11 splice acceptor site with an A at position -5 would have a lower information content (5.1 bits) than a splice acceptor site with a C at that position (7.5 bits) (Fig. 2). This analysis would predict that XPC mRNA from cells with the A at -5 would have a greater amount of alternatively spliced message that skipped exon 12 in comparison to cells with C at that position. A real-time QRT-PCR assay was developed utilizing an isoform-specific primer that spans the exon 11-exon 13 junction (oCCB-330; supplementary Fig. S1 and Table C) to measure XPC mRNA with deletion of exon 12. Skipping of exon 12 creates a premature stop codon which may trigger nonsense-mediated decay. Treatment of the fibroblasts with emetine prior to harvesting RNA stabilized this alternatively spliced product (8,20). Emetine treatment elevated the level of alternatively spliced XPC mRNA isoforms that deleted exon 4, 7 or 12 approximately 4- to 7-fold (data not shown). Normal fibroblasts with the A/A genotype had a 2.6-fold (P = 0.005) greater proportion of alternatively spliced XPC mRNA with deletion of exon 12 in comparison with cells from donors with the C/C genotype (Fig. 4A). The A/C heterozygotes had an intermediate level (1.8-fold, P = 0.01) of increase in the proportion of XPC mRNA with deletion of exon 12 (Fig. 4A). Similar results were seen in the absence of emetine (data not shown).
###end p 37
###begin p 38
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 135 140 <span type="species:ncbi:9606">human</span>
The real-time QRT-PCR assays were used to examine the relative proportion of XPC mRNA with deletion of exon 12 in a panel of 24 normal human tissues. While most tissues showed 0.1-0.5% skipping of exon 12, there was greater skipping (2-5% skipping) of exon 12 in muscle, bone marrow, fetal brain, plasma blood leukocytes and stomach (data not shown).
###end p 38
###begin title 39
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Function of XPC cDNA with deletion of exon 12
###end title 39
###begin p 40
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c21">21</xref>
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 304 311 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 528 529 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f4">4</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f4">4</xref>
###xml 1113 1114 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1120 1121 1120 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1141 1142 1141 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 781 788 <span type="species:ncbi:9606">patient</span>
A host cell reactivation assay (21) was employed to assess the function of wild-type XPC mRNA and alternatively spliced mRNA that skipped exon 12. This assay measures the ability of cells to repair DNA damage in a UV-treated plasmid (which contained a luciferase reporter gene) 2 days after transfection in vivo. The three normal fibroblast strains that were homozygous for the XPC intron 11 C/C genotype had significantly higher post-UV relative luciferase activity than that of three normal fibroblasts with the A/A genotype (P < 0.001) (Fig. 4B). The three normal fibroblasts with the A/C genotype had intermediate post-UV relative luciferase activity (Fig. 4B). Post-UV host cell reactivation was also measured in a lymphoblastoid cell line (XPH310BE) from the parent of an XP patient who is heterozygous for a mutation in intron 11 that leads to a elevated level (15.6%) of exon 12 skipping and from a normal donor (AG10107) with a low level (1%) of exon 12 skipping. There was a significantly lower level of relative luciferase activity in the XP heterozygote cells (8.0%) than in the normal cells (13.4%) (n = 6, P = 0.04, one tailed t-test) (data not shown). Both the fibroblast and lymphoblast results indicate that an increasing proportion of alternatively spliced XPC mRNA that skips exon 12 is associated with decreased DNA repair activity in normal cells.
###end p 40
###begin p 41
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f5">5</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f5">5</xref>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 850 853 850 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
In order to directly assess the function of the XPC mRNA that skips exon 12 we co-transfected expression vectors containing either wild-type XPC mRNA or XPC mRNA with deletion of exon 12 along with UV-treated luciferase plasmid (Fig. 5). Repair-deficient XP-C cells show very low post-UV luciferase expression relative to the untreated plasmid (Fig. 5A). Co-transfection of the XP-C cells with UV-treated plasmid along with another plasmid expressing wild-type XPC mRNA results in increased luciferase activity reflecting complementation of the DNA repair defect by the wild-type XPC cDNA. In contrast, co-transfection of the XP-C cells with a UV-treated luciferase plasmid along with a plasmid expressing XPC mRNA with deletion of exon 12 showed no significant complementation. These results indicate a lack of function of the alternatively spliced XPC mRNA isoform with deletion of exon 12.
###end p 41
###begin p 42
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f5">5</xref>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 424 427 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
The same assay was performed on wild-type cells to look for possible dominant negative effects of the alternatively spliced XPC isoform with deletion of exon 12 on DNA repair in normal cells. Normal cells were fully able to repair UV-induced DNA damage to the luciferase plasmid (Fig. 5B). There was no additional repair seen with co-transfection with wild-type XPC cDNA expression vector. In contrast, co-transfection with XPC cDNA plasmid expressing XPC mRNA with deletion of exon 12 showed lower activity, suggesting a dominant negative effect.
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c15">15</xref>
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 591 594 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 744 747 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPA</italic>
###xml 749 751 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c22">22</xref>
###xml 828 833 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 836 838 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c23">23</xref>
###xml 1002 1004 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c24">24</xref>
###xml 882 887 <span type="species:ncbi:9606">human</span>
###xml 1063 1068 <span type="species:ncbi:9606">human</span>
Rapid, sensitive, real-time QRT-PCR assays were developed to measure XPC message levels. This technique combines real-time quantitative PCR with reverse transcription of mRNA into cDNA. The advantages of this technique include a very large dynamic range and the capability for absolute quantitation of cDNA by the use of a standard curve. This technique is extremely sensitive, with the potential to measure <1 molecule/cell (15). The mean value of 295 fg pXPC-3 for the amount of normally spliced XPC cDNA derived from 50 ng total RNA (Table 2) corresponds to an average of approximately10 XPC mRNA molecules/cell, assuming 100% efficiency of the RT reaction. This number is similar to the 5-8 transcripts/cell estimated for another NER gene, XPA (22), and is in line with average transcript levels for other genes. Warrington et al. (23) looked at the expression of 7000 genes in human adult and fetal tissues and found that most transcripts were detected at </=5 copies/cell. Lockhart and Winzeler (24) found that the peak of the expression profile for 40 000 human genes lies between 5 and 10 copies/cell.
###end p 44
###begin p 45
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c9">9</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c14">14</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c14">14</xref>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Information theory is an important tool to rank normal and mutant splice junctions (9,14). Some of the exon and intron junctions were corrected based on genomic DNA sequencing and employing information theory. Most splice junctions that are fully functional have an information content of at least 2.4 bits (14). The XPC splice acceptor and donor sites all had very high information contents, ranging from 4.1 to 17.4 bits. The only exception was the exon 4 splice acceptor site, which had an information content of -0.1 bits.
###end p 45
###begin p 46
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 478 481 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 634 635 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 982 983 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
###xml 1142 1144 1130 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">65</sup>
###xml 1197 1199 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c25">25</xref>
###xml 1200 1202 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c26">26</xref>
###xml 1306 1307 1294 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb1">1</xref>
###xml 1368 1370 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c27">27</xref>
###xml 1508 1510 1496 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c28">28</xref>
We attempted to determine if a splice acceptor site with low information content was more likely to result in increased skipping of the following exon in comparison with an exon with high information content. The splice acceptors at exons 4 (-0.1 bits) and 7 (12.3 bits) were chosen for study since they had markedly different information contents. Accordingly, real-time QRT-PCR assays were developed to measure the level of XPC cDNA with deletion of exon 7 or 4. The level of XPC cDNA skipping exon 7 was very low, with an average of 0.07%. In contrast, the XPC cDNA skipping exon 4 was approximately10 times greater at 0.7% (Table 2). This indicates a relationship between information content and extent of exon skipping. The very low information content of the acceptor at exon 4 (-0.1 bits) would suggest that this would be a very poor splice site and result in even greater levels of exon 4 skipping than we observed. Examination of the exon 4 splice acceptor sequence (Table 1) reveals a run of five uridines upstream of five adenines. In spite of the low information content, the five uridines should be a strong binding site for U2AF65, the protein that recognizes polypyrimidine tracts (25,26). In addition, a strong splice donor (10.6 bits) lies 124 nt downstream at the 3' end of exon 4 (Table 1) and most likely functions as a splicing enhancer sequence (27). Additional intronic or exonic splicing enhancer elements may also be present and help to compensate for the poor splice acceptor site (28).
###end p 46
###begin p 47
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
A new SNP was discovered in the XPC intron 11 splice acceptor. This polymorphism results in lower information content in an acceptor with A (5.1 bits) than with C (7.5 bits). We predicted that more exon 12 skipping would be found in cells with the A/A genotype than in cells with the C/C genotype. Using a real-time QRT-PCR assay to measure the extent of skipping of exon 12 there was a genotype-dependent increase in skipping of exon 12.
###end p 47
###begin p 48
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c29">29</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c31">31</xref>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPG</italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c32">32</xref>
###xml 394 396 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c33">33</xref>
###xml 640 642 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c34">34</xref>
###xml 847 849 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c35">35</xref>
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 705 710 <span type="species:ncbi:9606">human</span>
###xml 747 752 <span type="species:ncbi:9606">human</span>
The presence of premature termination codons in the message decreases the levels of most (but not all) known mRNAs, a process called 'nonsense-mediated message decay' (29-31). Multiple alternatively spliced mRNA isoforms of the XPG gene have been described in normal tissues (32). Alternative splicing that eliminates the ATG start site in the XP-V gene (DNA polymerase eta) has been reported (33). Multiple splice variants of the human base excision repair protein, DNA polymerase beta, are common in normal bladder tissues and bladder cancer and appear to be related to the information content of the splice donor and acceptor sequences (34). Recent analyses of the EST database and the sequence of the human genome suggest that at least 38% of human mRNAs have alternatively spliced forms with an average of 2.75 splice forms per spliced gene (35). Thus alternative splicing significantly increases the size of the proteome.
###end p 48
###begin p 49
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c19">19</xref>
###xml 174 177 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 189 190 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f3">3</xref>
###xml 325 326 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 419 420 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 584 586 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c36">36</xref>
###xml 587 589 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c37">37</xref>
###xml 725 727 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c19">19</xref>
###xml 798 801 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 967 968 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f5">5</xref>
###xml 1097 1098 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf469f4">4</xref>
###xml 1190 1191 1178 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c6">6</xref>
###xml 1192 1194 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c38">38</xref>
###xml 570 575 <span type="species:ncbi:9606">human</span>
Two common polymorphisms were reported in the XPC gene: an intron 9 insertion/deletion polymorphism (PAT) and an exon 15 A/C polymorphism (19) approximately9 kb apart in the XPC gene (Fig. 3). There was non-disjunction between these polymorphisms and the intron 11 SNP. Thus the C of intron 11 appears to be linked to the PAT- allele and the exon 15 A allele in one haplotype covering at least 9 kb on chromosome 3. PAT+ is linked to the exon 15 C allele and the A in intron 11 in another haplotype. Haplotypes covering 3-84 kb on chromosome 5 have been reported in the human genome (36,37). There was equal DNA repair function of both the exon 15 A and the exon 15 C alleles as measured in the host cell reactivation assay (19). In contrast, deletion of exon 12 results in loss of function of the XPC cDNA in correcting the defect in XP-C cells with the host cell reactivation assay and also results in dominant negative inhibition of function in normal cells (Fig. 5A and B). We also found that increasing amounts of exon 12 skipping are associated with reduced DNA repair in normal cells (Fig. 4A and B). There is evidence that HHR23B protein binds to the exon 12 region of XPC protein (6,38).
###end p 49
###begin p 50
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf469c39">39</xref>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 653 656 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 753 756 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 819 822 819 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 942 945 942 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1032 1035 1032 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 946 954 <span type="species:ncbi:9606">patients</span>
Epidemiologic study of cancer patients showed that the PAT+/+ genotype was associated with a 1.85-fold increase in squamous cell carcinoma of the head and neck (39). The mechanism of this increased cancer risk has not been determined. The present study suggests a possible explanation. The PAT+ allele is in linkage disequilibrium with the A allele of intron 11 splice acceptor, which has a lower information content than the C allele and is associated with a higher frequency of deletion of exon 12. This exon 12 deleted XPC mRNA isoform has reduced DNA repair activity. While cells with the A/A genotype in intron 11 have normal levels of full-length XPC mRNA, there is evidence of a dominant negative suppression of DNA repair in normal cells by the XPC exon 12 deleted cDNA and reduced DNA repair in cells with the XPC intron 11 A/A genotype. Thus the increased cancer susceptibility may be related to a reduced level of DNA repair in PAT+/+ patients. This linkage analysis establishes a correlation between the genotype of the XPC gene and cancer predisposition.
###end p 50
###begin title 51
SUPPLEMENTARY MATERIAL
###end title 51
###begin p 52
Supplementary Material is available at NAR Online.
###end p 52
###begin title 53
[Supplementary material]
###end title 53
###begin title 54
Figures and Tables
###end title 54
###begin p 55
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
 Structural map of the human XPC gene. The 16 exons and 15 introns of the 33 kb XPC gene are numbered and their size in bp or kb is indicated below each segment. The parts of the genomic DNA sequence that we determined were submitted to GenBank (accession nos AF261892- AF261901). AC090645 is the chromosome 3 reference sequence that was later posted in GenBank.
###end p 55
###begin p 56
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 332 335 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fau</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fau</italic>
XPC intron 11 splice acceptor polymorphism. (Top) A C/A SNP is located at the -5 position of the XPC intron 11 splice acceptor. (Middle) The walkers indicate the change in splice acceptor information content from 7.5 to 5.1 bits by the polymorphism. (Lower) RFLP assay for detection of the C/A polymorphism by use of digestion with FauI. The 203 bp sequence generated by PCR is cut into fragments of 160 and 43 bp by FauI if the C is present in the sequence, permitting detection of C/C, C/A and A/A genotypes.
###end p 56
###begin p 57
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8211;</sup>
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 476 479 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 537 541 537 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2920</sub>
###xml 560 561 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 688 691 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 749 753 725 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2920</sub>
###xml 772 773 748 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
 Linkage disequilibrium among three XPC polymorphisms in 97 normal donors. (Upper) The number of donors with the XPC intron 9 PAT+/-, intron 11 A/C and exon 15 C/A genotypes is indicated on the bar graph. (Middle) The table shows the number of individuals homozygous for all three polymorphisms (in red or blue) or heterozygous for at least one of the polymorphisms (in black). (Lower) Schematic diagram of the physical location and haplotypes of three XPC polymorphisms. The XPC intron 11 splice acceptor A at position -5 is linked to C2920 in exon 15 and PAT+ in intron 9 in a haplotype covering approximately9 kb and occurring at a genotype frequency of approximately40% (in red). The XPC intron 11 splice acceptor C at position -5 is linked to A2920 in exon 15 and PAT- in intron 9 in a haplotype covering approximately9 kb and occurring at a genotype frequency of approximately60% (in blue).
###end p 57
###begin p 58
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
###xml 414 415 414 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf469tb2">2</xref>
 Relation of XPC intron 11 genotype to deletion of exon 12 in XPC mRNA and DNA repair function. (A) Real-time QRT-PCR was used to measure the amount of XPC mRNA deleting exon 12 and retaining exon 12. The proportion of deleted exon 12 XPC mRNA was significantly greater in cells with the A/A and A/C genotypes compared with the C/C genotype (the nine fibroblast lines assayed in duplicate are listed in Table 2). (B) Post-UV host cell reactivation was used to measure DNA repair function. The relative luciferase activity was significantly greater in the cells with the C/C genotype than in cells with the A/A genotype (the nine fibroblast lines assayed in triplicate are listed in Table 2).
###end p 58
###begin p 59
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 461 462 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 552 555 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 696 697 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 171 175 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 Post-UV host cell reactivation assay assessment of DNA repair activity of XPC cDNA deleting exon 12. (A) Increased expression of luciferase activity in XPC cells [XP4PA (SV40)] by co-transfection of full-length XPC cDNA expression vector (pcDNA3/HA-XPC) (solid circle) was not seen on co-transfection with the XPC cDNA expression vector deleted of exon 12 (pcDNA3/HA-XPC-deleted-exon 12) (solid triangle) or with the empty vector (pcDNA3/HA) (open triangle). (B) Reduction in expression of luciferase in normal cells (AG13129) by co-transfection with XPC cDNA expression vector deleted for exon 12 (solid triangle). Each data point represents an independent transfection. Data points at 1000 J/m2 are displaced for clarity.
###end p 59
###begin title 60
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human XPC gene: sequence and information content of splice sites
###end title 60
###begin title 61
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
Full-length (FL) and alternatively spliced XPC mRNA levels in normal fibroblasts
###end title 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aMean of two independent cultures analyzed for each cell strain.
###end p 62
###begin p 63
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bUnits are expressed in terms of fg control plasmid pXPC-3 (see Materials and Methods for details).
###end p 63
###begin title 64
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XPC</italic>
XPC intron 11 splice acceptor polymorphism allele frequencies and genotype distribution
###end title 64
###begin title 65
REFERENCES
###end title 65

